
About Ecron Acunova Limited
Data last updated:
Ecron Acunova Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Take Solutions Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2004PLC035260. Its GSTIN is 29AAECM1039J2ZD (Karnataka). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹42.98 Cr. It was formerly known as Molecular Cellular Research Pvt Ltd and Manipal Acunova Limited. It is led by directors including Ranganathan Praveen and Priya Jebarani Aldam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mobius Towers Sjr – I Park Epip Whitefield, Bangalore, Karnataka, India – 560066.
As per the financials filed for FY 2025, the company reported a revenue of ₹75.29 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹16.19 Cr (net margin 21.5%) and EBITDA of ₹11.04 Cr (EBITDA margin 14.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
The company has about 123 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Ecron and Navitas Life Sciences. As per MCA filings, the company has open charges of ₹102.69 Cr and satisfied charges of ₹147.21 Cr on record. Court records list 9 cases involving the company, including 3 filed by the company and 6 filed against it; 3 cases are pending. The company has 22 deals on record (12 funding rounds, 10 secondary share transfers), with disclosed funding of ₹79.04 Cr; the latest was in August 2016. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 1 smaller; the largest is QPS Bioserve India Private Limited with revenue of ₹78.02 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 665 overdue payments to 31 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website navitaslifesciences.com.
Company details
Name history
Ecron Acunova has undergone 3 name changes throughout its history. The company was previously known as Molecular Cellular Research Pvt Ltd, Manipal Acunova Limited, and Manipal Acunova Private Limited. The current legal name is Ecron Acunova Limited.
| Company Name | Status |
|---|---|
| Ecron Acunova Limited | Current |
| Molecular Cellular Research Pvt Ltd | Previous |
| Manipal Acunova Limited | Previous |
| Manipal Acunova Private Limited | Previous |
Contact details
Ecron Acunova Limited's registered office is in Bangalore, Karnataka. Its website is navitaslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMobius Towers Sjr – I Park Epip Whitefield, Bangalore, Karnataka, India – 560066
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Ecron Acunova Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ecron Acunova operates two associated brands: Ecron and Navitas Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manages solar energy projects, from design and installation to operations. | ecron.in | |
| Clinical, regulatory, safety and compliance services for clinical development | navitaslifesciences.com |
Business activity
The main business activity of Ecron Acunova is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Ecron Acunova Limited, buy the company report.
Financials of Ecron Acunova Limited
FY 2025 filings availableEcron Acunova Limited reported revenue of ₹75.29 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹75.29 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | ||||
| Net Profit Margin | 21.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ecron Acunova Limited, buy the company report.
Board of directors of Ecron Acunova Limited
Ecron Acunova has 3 current directors and 29 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranganathan Praveen Also directs: Sringaravalli Consultants Private Limited, CBCL Technologies and Services Private Limited, Cogence Tech Private Limited and 1 more | Additional Director | 15 Oct 2024 | 2 Years 1 Months | Current |
| Priya Jebarani Aldam | Additional Director | 15 Oct 2024 | 2 Years 1 Months | Current |
| Raghavendra Shetty | Additional Director | 20 Nov 2025 | 1 Years 0 Months | Current |
Peer comparison
Ecron Acunova Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| QPS Bioserve India Private Limited | ₹78.02 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Difgen Pharmaceuticals Private Limited | ₹76.63 Cr (FY 2025) | 84.0% | Hyderabad, Telangana, India | |||
| Ecron Acunova Limitedthis company | ₹75.29 Cr (FY 2025) | ₹16.19 Cr | 21.5% | 20.0% | 123 | Bangalore, Karnataka, India |
| RCC Laboratories India Private Limited | ₹68.9 Cr (FY 2025) | 31.0% | Telangana, India |
To see the full peer comparison of Ecron Acunova Limited, buy the company report.
Shareholding
The shareholding of Ecron Acunova Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ecron Acunova Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2017 | 100151156 | Others | ₹102.69 Cr | Satisfied | |
| 28 Jun 2013 | 10438703 | State Bank of India | ₹20 Lakh | Satisfied | |
| 27 Jul 2005 | 90193026 | State Bank of India | ₹44.32 Cr | Satisfied |
To see the full charge records of Ecron Acunova Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Ecron Acunova Limited has 22 deals on record (12 funding rounds, 10 secondary share transfers), with disclosed funding of ₹79.04 Cr; the latest was in August 2016.
Deals on record (5 of 22)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2010 | Secondary share transfer | Undisclosed | Buyer: Acunova Life Sciences Private Limited , Manipal Education And Medical Group India Private Limited, 2 individuals Seller: IL&FS Investment Managers, 2 individuals |
| Feb 2010 | Funding round | ₹4.17 Cr | Investors: Acunova Life Sciences Private Limited , an individual |
| Sep 2008 | Secondary share transfer | Undisclosed | Buyer: Manipal Education And Medical Group India Private Limited, 3 individuals Seller: Memg International India Private Limited , 3 individuals |
| Apr 2008 | Funding round | ₹60 Lakh | Investors: Acunova Life Sciences Private Limited |
| Jan 2008 | Funding round | ₹4.04 Cr | Investors: Acunova Life Sciences Private Limited , 3 individuals |
To see the full deal history of Ecron Acunova Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ecron Acunova Limited has 9 court cases on record: 3 filed by Ecron Acunova, 6 filed against it. 3 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 3 | 0 |
| District courts | 4 | 3 | 3 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by PDP Life Science Logistic India Pvt Ltd Through Its Auth Representative Irfan Khan | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by PDP Life Science Logistic India Pvt Ltd Through Its Auth Representative Irfan Khan | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by PDP Life Science Logistic India Pvt Ltd Through Its Auth Representative Irfan Khan | Pending |
| High Court of Karnataka | Court case (MFA) | Filed against the company by an individual | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Ecron Acunova Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ecron Acunova Limited was last rated by Care on 06 Sep 2023.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 06 Sep 2023 |
To see the full credit ratings and regulatory alerts of Ecron Acunova Limited, buy the company report.
MSME payment delays
Ecron Acunova Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 665 overdue payments to 31 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 31)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ultra International | |||
| MDC Healthcare Private Limited | |||
| Hta Instrumentation Private Limited | |||
| Radiant Specialty Diagnostics | |||
| an individual supplier |
To see the full MSME payment records of Ecron Acunova Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ecron Acunova Limited has a workforce of 123 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 123 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Ecron Acunova Limited, buy the company report.
GST
Ecron Acunova has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECM1039J2ZD | Karnataka | Active | 01 Jul 2017 |
| 33AAECM1039J1ZP | Tamil Nadu | Active | 31 Oct 2017 |
To see the full GST registrations and return filing status of Ecron Acunova Limited, buy the company report.
Recent activity
Ecron Acunova Limited has 27 board changes on record since 2009: 4 appointments and 23 cessations. The latest: Raghavendra Shetty was appointed as Additional Director on 20 Nov 2025.
26 earlier events are in the company report.
News
Frequently asked questions
Ecron Acunova is an active public limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 December 2004 (22+ years old) and is registered under CIN U73100KA2004PLC035260.
Ecron Acunova has 3 current directors:
- Ranganathan Praveen - Additional Director
- Priya Jebarani Aldam - Additional Director
- Raghavendra Shetty - Additional Director
The latest financial statements of Ecron Acunova on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ecron Acunova is 29AAECM1039J2ZD, registered in Karnataka. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 33AAECM1039J1ZP (Tamil Nadu).
The CIN (Corporate Identification Number) of Ecron Acunova is U73100KA2004PLC035260. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ecron Acunova has 9 court cases on record: 3 filed by the company and 6 filed against it. 3 are pending. Most are in the high courts.
Ecron Acunova was incorporated on 17 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.
Ecron Acunova has 22 deals on record (12 funding rounds, 10 secondary share transfers), with disclosed funding of ₹79.04 Cr; the latest was in August 2016.
The peers of Ecron Acunova by revenue are QPS Bioserve India Private Limited, Difgen Pharmaceuticals Private Limited, RCC Laboratories India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Raghavendra Shetty was appointed as Additional Director on 20 Nov 2025. Vedamirtham Venkatesan ceased to be CFO on 05 Nov 2024. Priya Jebarani Aldam was appointed as Additional Director on 15 Oct 2024. Ecron Acunova has 27 board changes on record in total.
Ecron Acunova has 9 MSME Form 1 returns on record between 2019 and 2023, listing 665 overdue payments to 31 micro and small suppliers. The latest return was filed on 29 Aug 2023.
Ecron Acunova can be reached through the website navitaslifesciences.com. Its registered office is in Bangalore, Karnataka, India.

